Onconetix, Inc. ONCO
Set alert
0.54 USD 0.00 0.00%
At close
0.54 0.00 -0.22%
Pre-market · Nov 3, 9:00 AM ET
Day range unavailable
0.342 52-week range 161.00
- YTD
- -99.30%
- 1 year
- -99.66%
- Open
- —
- Prev close
- 0.5428
- Mkt cap
- 3.20M
- Vol
- 0
- Avg vol
- 3.79M
- EPS
- 310.39
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.41
- Beta
- 3.73
- Short ratio
- 0.45
- Inst. own
- 7.86%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.23
- 200-d avg
- 4.94
- 1y target
- 0.00
MAX chart
Events in this range
- Dec 8, 2022Rating: Maxim Group · — → Buy
- Dec 9, 2022Rating: HC Wainwright & Co. · — → Buy
- Feb 1, 2023Rating: HC Wainwright & Co. · — → Buy
- Apr 26, 2023Rating: HC Wainwright & Co. · — → Buy
- Sep 13, 2023Downgrade: Maxim Group · Buy → Hold
- May 20, 2024Earnings: -6.4; estimate 0; surprise —%
- Aug 29, 2024Earnings: -9.2; estimate 0; surprise —%
- Sep 24, 2024Split: 1 for 40
- Dec 9, 2024Earnings: -2.24; estimate 0; surprise —%
- Jun 13, 2025Split: 1 for 85
- Mar 25, 2026Split: 1 for 5
- May 21, 2026Split: 1 for 10
- Nov 6, 2026Split: 1 for 10
Signals (55)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| RSI: Oversold | Mar 23, 2026 | 7 months ago |
| RSI: Oversold | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Nov 3, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Jun 9, 2025 | 1 year ago |
| SMA: Bullish | May 26, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bearish | Feb 17, 2025 | 1 year ago |
| SMA: Bullish | Jan 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 20, 2025 | 1 year ago |
| MACD: Sell Signal | Nov 4, 2024 | 1 year ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| SMA: Bearish | Oct 14, 2024 | 2 years ago |
| SMA: Bullish | Oct 7, 2024 | 2 years ago |
| SMA: Bullish | Oct 7, 2024 | 2 years ago |
Newest 20 of 55.
Financial health
Altman Z-Score
-13.08 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -16.5×
FY 2019 5y median -1345× FY 2025
P/S 314×
FY 2019 5y median 120× FY 2025
P/B 16.2×
FY 2019 5y median 31.5× FY 2025
P/FCF -26.4×
FY 2019 5y median -43.5× FY 2025
EV/EBITDA -18.9×
FY 2019 5y median -18.9× FY 2025
EV/Sales 308×
FY 2019 5y median 123× FY 2025
FCF Yield -3.8%
FY 2019 5y median -2.3% FY 2025
Profitability
Gross Margin 77.6%
FY 2019 5y median 0.0% FY 2025
Operating Margin -778.2%
FY 2019 5y median -778.2% FY 2025
Net Margin -1721.0%
FY 2019 5y median -1721.0% FY 2025
ROE -89.0%
FY 2019 5y median -89.0% FY 2025
ROIC -40.1%
FY 2019 5y median -60.2% FY 2025
ROA -56.3%
FY 2019 5y median -56.3% FY 2025
Growth (YoY)
Revenue -67.7%
FY 2019 FY 2025
Operating Income 88.8%
FY 2019 FY 2025
EPS (diluted) 99.1%
FY 2019 FY 2025
Free Cash Flow 8.0%
FY 2019 FY 2025
Financial Health
Current Ratio 0.7×
FY 2019 5y median 0.7× FY 2025
Quick Ratio 0.6×
FY 2019 5y median 0.6× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2019 5y median 0.4× FY 2025
Interest Coverage -8.4×
FY 2019 5y median -8.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31